NATCO Pharma Shares Plunge 19% After Q3 Earnings Miss
February 13, 2025 New Delhi, India Q3 Results Shares of NATCO Pharma Ltd. tumbled 19% on Thursday, February 13, after the company reported disappointing Q3 FY25 earnings, with a sharp decline in revenue, profit, and operating income. Q3 FY25 Earnings Highlights Net Profit: ₹132.4 crore, down 37.75% YoY (vs. ₹212.7 crore in Q3 FY24). Revenue…
